##gff-version 3
##sequence-region P17544 1 494
P17544	UniProtKB	Chain	1	494	.	.	.	ID=PRO_0000076592;Note=Cyclic AMP-dependent transcription factor ATF-7	
P17544	UniProtKB	Domain	343	406	.	.	.	Note=bZIP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
P17544	UniProtKB	Zinc finger	7	31	.	.	.	Note=C2H2-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
P17544	UniProtKB	Region	1	296	.	.	.	Note=Transactivation domain	
P17544	UniProtKB	Region	336	494	.	.	.	Note=Essential for binding adenovirus 2 E1A	
P17544	UniProtKB	Region	345	365	.	.	.	Note=Basic motif;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
P17544	UniProtKB	Region	371	399	.	.	.	Note=Leucine-zipper;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
P17544	UniProtKB	Modified residue	51	51	.	.	.	Note=Phosphothreonine%3B by MAPK11;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18950637;Dbxref=PMID:18950637	
P17544	UniProtKB	Modified residue	53	53	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18950637;Dbxref=PMID:18950637	
P17544	UniProtKB	Modified residue	112	112	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18950637;Dbxref=PMID:18950637	
P17544	UniProtKB	Modified residue	424	424	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:24275569	
P17544	UniProtKB	Modified residue	434	434	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P17544	UniProtKB	Cross-link	118	118	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17264123,ECO:0000269|PubMed:18950637;Dbxref=PMID:17264123,PMID:18950637	
P17544	UniProtKB	Alternative sequence	89	99	.	.	.	ID=VSP_000594;Note=In isoform 1%2C isoform 4 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:1694576,ECO:0000303|PubMed:8288576;Dbxref=PMID:15489334,PMID:1694576,PMID:8288576	
P17544	UniProtKB	Alternative sequence	100	494	.	.	.	ID=VSP_042469;Note=In isoform 5. AAAGPLDMSLPSTPDIKIKEEEPVEVDSSPPDSPASSPCSPPLKEKEVTPKPVLISTPTPTIVRPGSLPLHLGYDPLHPTLPSPTSVITQAPPSNRQMGSPTGSLPLVMHLANGQTMPVLPGPPVQMPSVISLARPVSMVPNIPGIPGPPVNSSGSISPSGHPIPSEAKMRLKATLTHQVSSINGGCGMVVGTASTMVTARPEQSQILIQHPDAPSPAQPQVSPAQPTPSTGGRRRRTVDEDPDERRQRFLERNRAAASRCRQKRKLWVSSLEKKAEELTSQNIQLSNEVTLLRNEVAQLKQLLLAHKDCPVTALQKKTQGYLESPKESSEPTGSPAPVIQHSSATAPSNGLSVRSAAEAVATSVLTQMASQRTELSMPIQSHVIMTPQSQSAGR->VFRPRLFLLCFGIIFLIG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P17544	UniProtKB	Alternative sequence	125	145	.	.	.	ID=VSP_000595;Note=In isoform 1 and isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:1694576;Dbxref=PMID:1694576	
P17544	UniProtKB	Alternative sequence	146	321	.	.	.	ID=VSP_034543;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8288576;Dbxref=PMID:8288576	
P17544	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Severely reduced TAF12-mediated enhancement of transcriptional activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15735663;Dbxref=PMID:15735663	
P17544	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Greatly reduced JNK2- or adenovirus E1A-mediated transactivation. Abolishes adenovirus 2 E1A-mediated transactivation%3B when associated with A-51%3B A-53 and G-112. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10376527;Dbxref=PMID:10376527	
P17544	UniProtKB	Mutagenesis	22	22	.	.	.	Note=No effect on binding adenovirus 2 E1A. Abolishes ATF7-mediated E1A responsiveness. D->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8417352;Dbxref=PMID:8417352	
P17544	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No effect on binding adenovirus 2 E1A. Abolishes ATF7-mediated E1A responsiveness. H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8417352;Dbxref=PMID:8417352	
P17544	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Severely reduced TAF12-induced transcriptional activity%3B when associated with S-35. M->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15735663;Dbxref=PMID:15735663	
P17544	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Severely reduced TAF12-induced transcriptional activity%3B when associated with D-33. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15735663;Dbxref=PMID:15735663	
P17544	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Severely reduced TAF12-induced transcriptional activity. No effect on MAPK9-mediated phosphorylation%3B when associated with A-53. Greatly reduces MAPK9- and adenovirus E1A-mediated transactivation%3B when associated with A-53 and G-112. Abolishes adenovirus 2 E1A-mediated transactivation%3B when associated with A-14%3B A-53 and G-112. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10376527,ECO:0000269|PubMed:15735663,ECO:0000269|PubMed:18950637;Dbxref=PMID:10376527,PMID:15735663,PMID:18950637	
P17544	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Completely abolishes MAPK9- and adenovirus E1A-mediated transactivation%3B when associated with D-53. T->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10376527,ECO:0000269|PubMed:15735663,ECO:0000269|PubMed:18950637;Dbxref=PMID:10376527,PMID:15735663,PMID:18950637	
P17544	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Severely reduced TAF12-induced transcriptional activity. No effect on MAPK9-mediated phosphorylation%3B when associated with A-51. Greatly reduces MAPK9- and adenovirus E1A-mediated transactivation%3B when associated with A-51 and G-112. Abolishes adenovirus 2 E1A-mediated transactivation%3B when associated with A-14%3B A-51 and G-112. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10376527,ECO:0000269|PubMed:15735663,ECO:0000269|PubMed:18950637;Dbxref=PMID:10376527,PMID:15735663,PMID:18950637	
P17544	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Completely abolishes MAPK9- and adenovirus E1A-mediated transactivation%3B when associated with D-51. T->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10376527,ECO:0000269|PubMed:15735663,ECO:0000269|PubMed:18950637;Dbxref=PMID:10376527,PMID:15735663,PMID:18950637	
P17544	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Some reduction in transactivation but%2C completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation%3B when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation%3B when associated with A-14%3B A-51 and A-53. T->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10376527,ECO:0000269|PubMed:18950637;Dbxref=PMID:10376527,PMID:18950637	
P17544	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Abolishes sumoylation. Exclusive nucleoplasmic location. Increase in binding the E-selectin promoter. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18950637;Dbxref=PMID:18950637	
P17544	UniProtKB	Mutagenesis	156	156	.	.	.	Note=No effect on transactivation%3B when associated with A-158. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10376527;Dbxref=PMID:10376527	
P17544	UniProtKB	Mutagenesis	158	158	.	.	.	Note=No effect on transactivation%3B when associated with A-156. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10376527;Dbxref=PMID:10376527	
P17544	UniProtKB	Sequence conflict	12	12	.	.	.	Note=P->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
